Breaking News Instant updates and real-time market news.

2020-11-25 16:30:01 16:30 11/25/20 11/25 16:30 11/25/20 16:30	Preliminary option volume of 32.5M today Preliminary option volume of 32.5M today is 0% below recent average. Calls led puts 21.12M to 11.43M.

2020-11-25 16:30:01

16:30

11/25/20

11/25

16:30

11/25/20

16:30

Preliminary option volume of 32.5M today

Preliminary option volume of 32.5M today is 0% below recent average. Calls led puts 21.12M to 11.43M.

TODAY'S FREE FLY STORIES

Upgrade	Netflix upgraded to Overweight from Equal Weight at Wells Fargo » 05:11 01/20/21 01/20 05:11 01/20/21 05:11 NFLX Netflix $501.85 / +3.9 (+0.78%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $501.85 / +3.9 (+0.78%) 05:01 Today Piper Sandler Netflix price target raised to $652 from $643 at Piper Sandler 04:52 Today Pivotal Research Netflix price target raised to $750 from $660 at Pivotal Research 04:41 Today UBS Netflix upgraded to Buy from Neutral at UBS 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st
Downgrade	Bloom Energy downgraded to Neutral from Outperform at Credit Suisse » 05:06 01/20/21 01/20 05:06 01/20/21 05:06 BE Bloom Energy $39.89 / +3.41 (+9.35%) Credit Suisse analyst… Credit Suisse analyst Michael Weinstein downgraded Bloom Energy to Neutral from Outperform with a price target of $32, up from $27. The stock closed Tuesday up 9% to $39.93. The analyst increased the price target to reflect higher 2024 and 2025 growth rates due to a two year federal solar tax credit extension and potentially favorable zero-carbon policy under President Biden. Weinstein, however, downgrades Bloom due to valuation. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BE Bloom Energy $39.89 / +3.41 (+9.35%) 12/09/20 Bloom Energy falls -15.3% 11/18/20 Bloom Energy, SK E&C announce they won RFP to supply SOFC in Korea 09/18/20 Bloom Energy rises 18.1% 09/18/20 Bloom Energy rises 10.7% BE Bloom Energy $39.89 / +3.41 (+9.35%) 01/14/21 JPMorgan Bloom Energy price target raised to $35 from $26 at JPMorgan 01/12/21 Morgan Stanley Morgan Stanley downgrades 2020 top performer Bloom Energy to Equal Weight 01/12/21 Morgan Stanley Bloom Energy downgraded to Equal Weight from Overweight at Morgan Stanley 12/21/20 Morgan Stanley Bloom Energy price target raised to $32 from $21 at Morgan Stanley BE Bloom Energy $39.89 / +3.41 (+9.35%) 10/29/20 Bloom Energy reports Q3 net loss $12.0M 07/28/20 Bloom Energy not providing guidance for Q3 07/28/20 Bloom Energy reports preliminary Q2 revenue $187.9M, consensus $171.22M 15 Oct 02 Oct BE Bloom Energy $39.89 / +3.41 (+9.35%) 12/08/20 Rapidly changing industry foiled Bloom Energy's vision, WSJ says 10/14/20 Bloom Energy holder Canada Pension Plan exiting stake, Bloomberg says 07/25/20 Bubble forming in Hydrogen fuel-cell stocks, Barron's says BE Bloom Energy $39.89 / +3.41 (+9.35%) 10/29/20 Fly Intel: After-Hours Movers 10/12/20 Fly Insider: Element Solutions, Sunrun among week's notable insider trades 08/03/20 Fly Insider: Montrose, Centene among week's notable insider transactions 07/28/20 Fly Intel: After-Hours Movers 02/10/21 Bloom Energy - BE BE Bloom Energy $39.89 / +3.41 (+9.35%) 12/08/20 Bloom Energy call volume above normal and directionally bullish 12/04/20 Bloom Energy call volume above normal and directionally bullish 11/24/20 Bloom Energy call volume above normal and directionally bullish 11/23/20 Bloom Energy call volume above normal and directionally bullish
Upgrade	Megaport upgraded to Buy from Neutral at Goldman Sachs » 05:03 01/20/21 01/20 05:03 01/20/21 05:03 MGPPF Megaport $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research MGPPF Megaport $0.00 / + (+0.00%) 08/17/20 Megaport announces upcoming release of Megaport Virtual Edge MGPPF Megaport $0.00 / + (+0.00%) 08/06/20 Canaccord Megaport upgraded to Buy from Hold at Canaccord
Recommendations	Netflix price target raised to $652 from $643 at Piper Sandler » 05:01 01/20/21 01/20 05:01 01/20/21 05:01 NFLX Netflix $501.85 / +3.9 (+0.78%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $501.85 / +3.9 (+0.78%) 04:52 Today Pivotal Research Netflix price target raised to $750 from $660 at Pivotal Research 04:41 Today UBS Netflix upgraded to Buy from Neutral at UBS 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/15/21 Citi Citi cuts Spotify to Sell with no benefit seen on podcast investments NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st
Downgrade	ShockWave Medical downgraded to Neutral from Overweight at Piper Sandler » 05:00 01/20/21 01/20 05:00 01/20/21 05:00 SWAV ShockWave Medical $142.06 / +5 (+3.65%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events SWAV ShockWave Medical $142.06 / +5 (+3.65%) 12/04/20 ShockWave Medical says CMS creates four new codes for IVL procedures 11/08/20 ShockWave announces unveiling of data from Disrupt PAD III study 10/15/20 ShockWave reports Disrupt CAD III met primary safety, effectiveness endpoints 10/01/20 ShockWave Medical announces updated time for CAD III Investor Webcast Event SWAV ShockWave Medical $142.06 / +5 (+3.65%) 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler 01/12/21 Wells Fargo ShockWave Medical price target raised to $134 from $95 at Wells Fargo 12/03/20 Piper Sandler Piper boosts ShockWave Medical target to $96, likes setup into 2021 12/02/20 Oppenheimer Oppenheimer stays at Perform on ShockWave, highlights paper on IVL-induced VFib SWAV ShockWave Medical $142.06 / +5 (+3.65%) 11/09/20 ShockWave Medical reports Q3 EPS (38c), consensus (55c) 08/11/20 ShockWave Medical reports Q2 EPS (56c), consensus (62c) 17 Jun 02/17/21 ShockWave Medical - SWAV

Downgrade	Global Blood downgraded to Neutral from Overweight at Piper Sandler » 04:58 01/20/21 01/20 04:58 01/20/21 04:58 GBT Global Blood Therapeutics $50.81 / +0.83 (+1.66%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly GBT Global Blood Therapeutics $50.81 / +0.83 (+1.66%) 01/07/21 Global Blood Therapeutics announces employment inducement grants 12/07/20 Global Blood Therapeutics appoints Kim Smith-Whitley as head of R&D 12/06/20 Global Blood presents new data on long-term, real-world use of Oxbryta tablets 12/06/20 Global Blood presents data on new sickle cell disease pipeline therapies GBT Global Blood Therapeutics $50.81 / +0.83 (+1.66%) 12/15/20 H.C. Wainwright Global Blood Therapeutics assumed with a Buy at H.C. Wainwright 12/03/20 Fly Intel: Top five analyst initiations 12/03/20 RBC Capital Global Blood Therapeutics initiated with an Outperform at RBC Capital 11/18/20 Cantor Fitzgerald Global Blood Therapeutics price target lowered to $120 from $133 at Cantor Fitzgerald GBT Global Blood Therapeutics $50.81 / +0.83 (+1.66%) 11/05/20 Global Blood Therapeutics reports Q3 EPS ,(97c) consensus (73c) 08/05/20 Global Blood Therapeutics reports Q2 EPS (86c), consensus ($1.15) GBT Global Blood Therapeutics $50.81 / +0.83 (+1.66%) 11/06/20 Fly Intel: Wall Street's top stories for Friday 11/06/20 Fly Intel: Wall Street's top stories at midday 11/06/20 Square, AMD upgrades among today's top calls on Wall Street
Recommendations	Omnicell price target raised to $140 from $125 at Benchmark » 04:57 01/20/21 01/20 04:57 01/20/21 04:57 OMCL Omnicell $121.56 / +0.71 (+0.59%) Benchmark analyst Bill… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events OMCL Omnicell $121.56 / +0.71 (+0.59%) 12/08/20 Omnicell jumps 16.5% to $128 after reported takeover interest from Baxter 08/12/20 Omnicell to acquire 340B Link business from PSG for $225M 07/28/20 Omnicell remains unable to provide FY20 guidance at this time 07/28/20 Omnicell confident in overall health of business OMCL Omnicell $121.56 / +0.71 (+0.59%) 01/14/21 Craig-Hallum Omnicell price target raised to $142 from $100 at Craig-Hallum 12/09/20 Piper Sandler Pontential Baxter, Omnicell deal makes sense, says Piper Sandler 12/09/20 Benchmark Omnicell price target raised to $125 from $100 at Benchmark 12/08/20 Berenberg Berenberg starts four healthcare technology companies with Buy ratings OMCL Omnicell $121.56 / +0.71 (+0.59%) 01/13/21 Omnicell sees FY21EPS $3.38-$3.58, consensus $3.10 01/13/21 Omnicell raises FY20 EPS view to $2.46-$2.51, consensus $2.38 01/13/21 Omnicell raises FY20 EPS view to $2.46-$2.51, consensus $2.38 10/27/20 Omnicell sees FY21 revenue $1.015B-$1.045B, consensus $990.76M OMCL Omnicell $121.56 / +0.71 (+0.59%) 12/09/20 Baxter willing to pay over $125 per share for Omnicell, CNBC reports 12/09/20 Baxter not willing to go hostile to acquire Omnicell, CNBC reports 12/09/20 Omnicell board rejected Baxter takeover bid, CNBC reports 12/09/20 Baxter willing to pay over $125 per share for Omnicell, CNBC reports OMCL Omnicell $121.56 / +0.71 (+0.59%) 12/09/20 Fly Intel: Wall Street's top stories for Wednesday 12/09/20 Fly Intel: Wall Street's top stories at midday 12/09/20 Fly Intel: Pre-market Movers 12/08/20 Fly Intel: After-Hours Movers 02/01/21 Omnicell - OMCL
Upgrade	Lumentum upgraded to Buy from Neutral at Goldman Sachs » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 LITE Lumentum $94.50 / -11.69 (-11.01%) , COHR Coherent $197.01 / +45.09 (+29.68%) Goldman Sachs analyst Rod… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LITE COHR LITE Lumentum $94.50 / -11.69 (-11.01%) 01/19/21 Lumentum to acquire Coherent in $5.7B cash and stock transaction, sees accretion 11/16/20 Lumentum acquires TriLumina assets; terms not disclosed 09/04/20 FCC says U.S. rural telecom networks need $1.84B to remove Huawei, ZTE equipment 08/11/20 Lumentum CEO says 'better than projected results' in Q4 COHR Coherent $197.01 / +45.09 (+29.68%) 01/19/21 Lumentum to acquire Coherent in $5.7B cash and stock transaction, sees accretion 12/16/20 Coherent, II-VI enter supply agreement 12/16/20 II-VI, Coherent enter supply agreement for automotive laser welding solutions 11/10/20 Coherent CEO says 'cautiously optimistic on 5G upgrade cycle LITE COHR LITE Lumentum $94.50 / -11.69 (-11.01%) 01/19/21 Craig-Hallum Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum 01/12/21 MKM Partners Lumentum price target raised to $138 from $120 at MKM Partners 01/12/21 Susquehanna Susquehanna names top five M&A candidates in Semi space 01/11/21 B. Riley Securities Lumentum price target raised to $123 from $101 at B. Riley Securities COHR Coherent $197.01 / +45.09 (+29.68%) 01/19/21 Craig-Hallum Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum 01/12/21 Barclays Coherent downgraded to Underweight from Equal Weight at Barclays 11/12/20 Longbow Coherent downgraded to Neutral ahead of transition year at Longbow 11/12/20 Longbow Coherent downgraded to Neutral from Buy at Longbow LITE COHR LITE Lumentum $94.50 / -11.69 (-11.01%) 01/19/21 Lumentum reports preliminary Q2 EPS $1.91-$1.99, consensus $1.82 11/02/20 Lumentum sees Q2 non-GAAP EPS $1.70-$1.90, consensus $1.60 11/02/20 Lumentum reports Q1 non-GAAP EPS $1.78, consensus $1.47 08/11/20 Lumentum sees Q1 adjusted EPS $1.40-$1.55, consensus $1.33 COHR Coherent $197.01 / +45.09 (+29.68%) 01/19/21 Coherent reports preliminary Q1 revenue $325M-$327M, consensus $313.09M 11/10/20 Coherent sees Q1 revenue $300M-$320M, consensus $341.28M 11/10/20 Coherent reports Q4 adjusted EPS $1.01, consensus 80c 08/04/20 Coherent sees Q4 revenue $290M-$320M, consensus $325.49M LITE COHR LITE Lumentum $94.50 / -11.69 (-11.01%) 01/19/21 NeoPhotonics speculated as potential takeover target at Dealreporter 01/18/21 Lumentum in advanced talks to acquire Coherent, WSJ reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says COHR Coherent $197.01 / +45.09 (+29.68%) 01/19/21 NeoPhotonics speculated as potential takeover target at Dealreporter 01/18/21 Lumentum in advanced talks to acquire Coherent, WSJ reports LITE COHR LITE Lumentum $94.50 / -11.69 (-11.01%) 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Lumentum slides after announcing $5.7B merger deal with Coherent 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers COHR Coherent $197.01 / +45.09 (+29.68%) 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Lumentum slides after announcing $5.7B merger deal with Coherent 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 02/11/21 Technology & Internet Virtual Conference 02/02/21 Lumentum - LITE LITE LITE Lumentum $94.50 / -11.69 (-11.01%) 01/05/21 Lumentum call volume above normal and directionally bullish 08/17/20 Lumentum put volume heavy and directionally bearish 08/03/20 Lumentum call volume above normal and directionally bullish
General news	Week of 1/15 MBA Mortgage Applications to be released at 07:00 04:55 01/20/21 01/20 04:55 01/20/21 04:55
Conference/Events	Scorpio Tankers management to meet virtually with BTIG » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 STNG Scorpio Tankers $12.80 / -0.98 (-7.11%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options STNG Scorpio Tankers $12.80 / -0.98 (-7.11%) 12/21/20 Scorpio Tankers announces purchase of common shares by Scorpio Services 09/24/20 Scorpio Tankers financing activity to increase liquidity by $82M 09/24/20 Scorpio Tankers announces purchase of common shares by Scorpio Services 09/08/20 Scorpio Tankers announces new $250M Securities Repurchase Program STNG Scorpio Tankers $12.80 / -0.98 (-7.11%) 07/28/20 Deutsche Bank Scorpio Tankers price target lowered to $27 from $42 at Deutsche Bank 06/19/20 B. Riley FBR Scorpio Tankers price target lowered to $45 from $55 at B. Riley FBR 06/04/20 Pareto Scorpio Tankers downgraded to Hold from Buy at Pareto 06/02/20 Fearnley Scorpio Tankers downgraded to Sell from Hold at Fearnley STNG Scorpio Tankers $12.80 / -0.98 (-7.11%) 11/05/20 Scorpio Tankers reports Q3 adjusted EPS 37c, consensus (35c) 08/06/20 Scorpio Tankers reports Q2 adjusted EPS $2.40, consensus $2.88 00:00 Today Scorpio Tankers STNG Scorpio Tankers $12.80 / -0.98 (-7.11%) 10/29/20 Scorpio Tankers call volume above normal and directionally bullish 10/13/20 Scorpio Tankers call volume above normal and directionally bullish 09/11/20 Scorpio Tankers call volume above normal and directionally bullish 08/10/20 Scorpio Tankers call volume above normal and directionally bullish

Conference/Events	Horizon Technology management to meet virtually with B. Riley Securities » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 HRZN Horizon Technology $13.45 / -0.2 (-1.47%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 7 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events HRZN Horizon Technology $13.45 / -0.2 (-1.47%) 09/02/20 Celsion restructures strategic loan facility 07/28/20 Horizon Technolog declares monthly cash distributions of 10c HRZN Horizon Technology $13.45 / -0.2 (-1.47%) 01/14/21 Compass Point Horizon Technology downgraded to Sell from Neutral at Compass Point 11/19/20 JMP Securities TriplePoint Venture resumed with an Outperform at JMP Securities 09/23/20 Fly Intel: Top five analyst initiations 09/23/20 National Securities Horizon Technology initiated with a Neutral at National Securities HRZN Horizon Technology $13.45 / -0.2 (-1.47%) 11/03/20 Horizon Technology reports Q3 NII 34c, consensus 31c 07/28/20 Horizon Technology reports Q2 EPS 40c, consensus 29c 00:00 Today Horizon Technology
Conference/Events	Arcus Biosciences management to meet virtually with Mizuho » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 RCUS Arcus Biosciences $36.74 / -0.26 (-0.70%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events RCUS Arcus Biosciences $36.74 / -0.26 (-0.70%) 01/15/21 Arcus Biosciences presents preliminary data from ARC-8 study 12/09/20 Arcus Biosciences expands partnership with WuXi on anti-CD39 antibodies 11/13/20 Surface announces SRF617, SRF388 to advance to combination, expansion stages 10/29/20 Arcus Biosciences to collaborate with AstraZeneca on trial for domvanalimab RCUS Arcus Biosciences $36.74 / -0.26 (-0.70%) 01/19/21 Wedbush Arcus Biosciences price target raised to $55 from $48 at Wedbush 01/19/21 Truist Arcus Biosciences price target raised to $70 from $45 at Truist 01/13/21 Cantor Fitzgerald Arcus Biosciences price target raised to $62 from $39 at Cantor Fitzgerald 12/22/20 Mizuho Autolus, Arcus among top 2021 oncology picks at Mizuho RCUS Arcus Biosciences $36.74 / -0.26 (-0.70%) 11/05/20 Arcus Biosciences reports Q3 EPS 3c, consensus 5c 08/06/20 Arcus Biosciences reports Q2 EPS (93c), consensus (61c) 29 May 00:00 Today Arcus Biosciences
Conference/Events	WD-40 management to meet virtually with Oppenheimer » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 WDFC WD-40 $279.69 / -1.31 (-0.47%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 7 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WDFC WD-40 $279.69 / -1.31 (-0.47%) 01/07/21 WD-40 jumps 11% to $298.41 after Q1 results beat estimates 01/07/21 WD-40 CEO says 'off to a very strong start in fiscal year 2021' 11/10/20 WD-40 CFO Remboltd, General Counsel Clampitt announce retirement intentions 10/20/20 WD-40 jumps 11% to $220 after Q4 results beat estimates WDFC WD-40 $279.69 / -1.31 (-0.47%) 01/08/21 DA Davidson WD-40 price target raised to $353 from $250 at DA Davidson 07/10/20 DA Davidson WD-40 price target raised to $233 from $212 at DA Davidson 03/27/20 DA Davidson WD-40 upgraded to Buy from Neutral at DA Davidson 03/27/20 DA Davidson WD-40 upgraded to Buy from Neutral at DA Davidson WDFC WD-40 $279.69 / -1.31 (-0.47%) 01/07/21 WD-40 sees FY21 revenue $435M-$470M, consensus $426.24M 01/07/21 WD-40 reports Q1 EPS $1.72, one estimate $1.03 10/20/20 WD-40 reports Q4 EPS $1.42, consensus $1.13 WDFC WD-40 $279.69 / -1.31 (-0.47%) 01/07/21 Fly Intel: After-Hours Movers 10/20/20 Fly Intel: After-Hours Movers 00:00 Today WD-40
Conference/Events	Noble Capital to hold a virtual conference » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 XBIO Xenetic $2.73 / -0.02 (-0.73%) , CLBS Caladrius $1.64 / +0.085 (+5.48%) , IPOOF InPlay Oil $0.00 / + (+0.00%) , UUUU Energy Fuels $3.92 / -0.065 (-1.63%) , EXK Endeavour Silver $4.28 / +0.065 (+1.54%) , CPST Capstone Turbine $12.05 / +0.085 (+0.71%) , INDO Indonesia Energy $6.18 / +0.38 (+6.55%) , SMTS Sierra Metals $3.66 / +0.05 (+1.39%) , CTXR Citius Pharmaceuticals $1.18 / +0.06 (+5.36%) , JAGX Jaguar Health $3.26 / -0.01 (-0.31%) , CURR CURE Pharmaceutical $0.00 / + (+0.00%) , MIND MIND Technology $2.15 / -0.02 (-0.92%) , SSP E.W. Scripps $15.62 / +0.77 (+5.19%) , LODE Comstock Mining $1.23 / -0.01 (-0.81%) , VGZ Vista Gold $0.95 / -0.0432 (-4.35%) , AYLA Ayala Pharmaceuticals $14.65 / +1.85 (+14.45%) , STMH Stem Holdings $0.00 / + (+0.00%) , EGLE Eagle Bulk Shipping $23.25 / +0.08 (+0.35%) , SALM Salem Media $1.61 / +0.04 (+2.55%) , AEZS Aeterna Zentaris $0.69 / +0.0543 (+8.54%) , GLDD Great Lakes Dredge $13.86 / -0.21 (-1.49%) , INSW International Seaways $17.53 / -0.71 (-3.89%) 17th Annual Small &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XBIO CLBS IPOOF UUUU EXK CPST SMTS CTXR JAGX CURR MIND SSP LODE VGZ AYLA STMH EGLE SALM AEZS GLDD INSW XBIO Xenetic $2.73 / -0.02 (-0.73%) 12/09/20 Xenetic announces its partner reported data from study leveraging PolyXen CLBS Caladrius $1.64 / +0.085 (+5.48%) 01/19/21 Caladrius initiates Phase 2b trial of CLBS16 in coronary disfunction 12/14/20 Caladrius expects available capital fo fund company through 2021 12/14/20 Caladrius suspends execution of current pilot study of CLBS119 12/14/20 Caladrius provides year-end 2020 strategic portfolio update IPOOF InPlay Oil $0.00 / + (+0.00%) 11/02/20 InPlay Oil board approves Q4 exploration and development capital program 11/02/20 InPlay Oil closes Cardium asset acquisition 11/02/20 InPlay Oil finalizes BDC term facility UUUU Energy Fuels $3.92 / -0.065 (-1.63%) 12/14/20 Energy Fuels enters three-year monazite supply agreement with Chemours 09/21/20 Energy Fuels, Penn State to be awarded DOE contract for REO production 09/14/20 Energy Fuels call U.S. agreement with Russia 'important step' 08/20/20 Energy Fuels COO W. Paul Goranson to leave company, effective August 31 EXK Endeavour Silver $4.28 / +0.065 (+1.54%) 01/08/21 Endeavour Silver falls -9.9% 01/08/21 Endeavour Silver falls -7.1% 01/07/21 Endeavour Silver reports Q4 production of 2.1M silver equivalent oz. 12/18/20 Endeavour Silver to sell El Cubo Mine to VanGold Mining for $15M plus payments CPST Capstone Turbine $12.05 / +0.085 (+0.71%) 01/11/21 Capstone Turbine announces several orders for eight C65 microturbines 12/29/20 Capstone Turbine announces 10% ITC extended through 2023 in stimulus package 12/22/20 Capstone Turbine gets follow-on order from latex-based manufacturer 12/16/20 Capstone Turbine announces Horizon Power Systems renews FPP service pact SMTS Sierra Metals $3.66 / +0.05 (+1.39%) 01/08/21 Sierra Metals to explore potential strategic alternatives, including sale 12/10/20 Sierra Metals announces positive PEA results for Cusi Mine production increase 11/18/20 Sierra Metals reports mineral resource increase at Yauricocha Mine, Peru 11/18/20 Sierra Metals raises mineral resource estimate for Cusi Silver Mine, Mexico CTXR Citius Pharmaceuticals $1.18 / +0.06 (+5.36%) 12/09/20 Citius Pharmaceuticals receives FDA response to pre-IND submission for Mino-Wrap 12/08/20 Citius Pharmaceuticals reports data from POC study of i-MSC therapy 11/30/20 Citius Pharmaceuticals: Mino-Lok 'superior' to EDTA/ethanol in BA study 10/13/20 Novellus Therapeutics licenses iMSCs to Citius Pharmaceuticals' NoveCite JAGX Jaguar Health $3.26 / -0.01 (-0.31%) 12/23/20 Jaguar Health in $6M financing transaction involving royalty rights 12/07/20 Nasdaq listing panel to evaluate time period give to Jaguar on minimum bid rule 12/04/20 Jaguar Health enters fifth amendment to accounts receivable agreement with Oasis 10/29/20 Jaguar Health gets extension from Nasdaq to December 23 for minimum bid CURR CURE Pharmaceutical $0.00 / + (+0.00%) 01/05/21 CURE Pharmaceutical receives FDA approval for CUREfilm Blue IND application 07/30/20 CURE Pharmaceutical to acquire Sera Labs in $20M transaction 07/28/20 CURE Pharmaceutical to acquire Sera Labs in $20M transaction MIND MIND Technology $2.15 / -0.02 (-0.92%) 12/01/20 MIND Technology announces orders for source controller upgrades 08/04/20 Mitcham Industries completes reincorporation from Texas to Delaware SSP E.W. Scripps $15.62 / +0.77 (+5.19%) 01/15/21 E.W. Scripps jumps 6% to $15.75 after Berkshire Hathaway disclosed stake 01/15/21 Berkshire Hathaway reports 24.9% passive stake in E.W. Scripps 01/07/21 E.W. Scripps completes 'highly accretive' acquisition of ION Media Networks 12/30/20 E.W. Scripps completes WPIX sale, to use cash for ION Media acquisition LODE Comstock Mining $1.23 / -0.01 (-0.81%) 01/07/21 Comstock Mining povides update on 2021-2023 outlook and plan 09/14/20 Comstock Mining completes Lucerne sale, recognizes $18M gain 09/09/20 Comstock Mining extends mineral leases, secures strategic purchase option 09/02/20 Comstock Mining to lease, sell Daney Ranch for $2.7M VGZ Vista Gold $0.95 / -0.0432 (-4.35%) 01/14/21 Vista Gold CEO provides 2021 outlook 01/11/21 Vista Gold receives $1.1M Guadalupe de los Reyes payment 11/30/20 Vista Gold, Jawoyn Association modify agreement to include royalty 07/20/20 Vista Gold receives $1.5M Guadalupe de los Reyes payment AYLA Ayala Pharmaceuticals $14.65 / +1.85 (+14.45%) 01/04/21 Ayala Pharmaceuticals to accelerate AL102 development in Phase 2/3 study 11/17/20 Ayala Pharmaceuticals announces upcoming milestones 11/17/20 Ayala Pharmaceuticals expects cash to fund operations into 2H22 09/18/20 Ayala Pharmaceuticals presents interim data from Phase 2 ACCURACY trial of AL101 STMH Stem Holdings $0.00 / + (+0.00%) 12/30/20 Stem Holdings closes acquisition of Driven Deliveries 12/08/20 Stem Holdings announces product lineup for 2021 11/16/20 Driven Deliveries announces partnership with Pabst Labs 10/13/20 Stem Holdings expands product line with first co-branded product EGLE Eagle Bulk Shipping $23.25 / +0.08 (+0.35%) 12/29/20 Eagle Bulk Shipping acquires two SDARI-64 scrubber-fitted Ultramax bulkcarriers 12/22/20 Eagle Bulk Shipping becomes signatory to Sea Cargo Charter 12/16/20 Eagle Bulk Shipping acquires Ultramax bulkcarrier for $16M 09/15/20 Eagle Bulk Shipping announces effectiveness of 1-for-7 reverse stock split SALM Salem Media $1.61 / +0.04 (+2.55%) 07/22/20 FCC reaches settlements with radio group owners over political files AEZS Aeterna Zentaris $0.69 / +0.0543 (+8.54%) 12/07/20 Aeterna Zentaris enters European licensing agreement with Consilient Health 11/16/20 Aeterna Zentaris amends license agreement with Novo Nordisk 11/06/20 Aeterna Zentaris expects cash to be sufficient through 2023 09/16/20 Aeterna Zentaris to restablish 'diversified, yet focused' development pipeline GLDD Great Lakes Dredge $13.86 / -0.21 (-1.49%) 01/11/21 Great Lakes Dredge receives $60.9M in awarded work 11/17/20 Great Lakes Dredge selected by NextDecade to perform channel improvements 10/02/20 Great Lakes Dredge receives $59.8M in awarded work 09/25/20 Great Lakes Dredge receives $105M Jacksonville deepening award INSW International Seaways $17.53 / -0.71 (-3.89%) 11/04/20 International Seaways wins 10-year contract extensions for FSO JVs XBIO CLBS IPOOF UUUU EXK CPST INDO SMTS CTXR JAGX CURR MIND SSP LODE VGZ AYLA STMH EGLE SALM AEZS GLDD INSW XBIO Xenetic $2.73 / -0.02 (-0.73%) 01/11/21 H.C. Wainwright Xenetic price target raised to $5 from $2 at H.C. Wainwright 05/04/20 H.C. Wainwright Xenetic initiated with a Buy at H.C. Wainwright CLBS Caladrius $1.64 / +0.085 (+5.48%) 01/19/21 H.C. Wainwright Caladrius price target lowered to $14 from $18.50 at H.C. Wainwright 05/22/20 Brookline Caladrius initiated with a Buy at Brookline 05/18/20 Dawson James Caladrius downgraded to Neutral from Buy at Dawson James IPOOF InPlay Oil $0.00 / + (+0.00%) 01/08/21 Canaccord InPlay Oil positioned for success, Canaccord upgrades to Speculative Buy 01/08/21 Canaccord InPlay Oil upgraded to Speculative Buy from Hold at Canaccord 03/10/20 Canaccord InPlay Oil downgraded to Hold from Buy at Canaccord UUUU Energy Fuels $3.92 / -0.065 (-1.63%) 01/13/21 Cantor Fitzgerald Energy Fuels upgraded to Buy from Hold at Cantor Fitzgerald 01/06/21 Cantor Fitzgerald Energy Fuels downgraded to Hold from Buy at Cantor Fitzgerald 12/14/20 Cantor Fitzgerald Cameco downgraded to Hold from Buy at Cantor Fitzgerald 03/03/20 LD Micro to hold a virtual conference EXK Endeavour Silver $4.28 / +0.065 (+1.54%) 01/08/21 BMO Capital Endeavour Silver price target raised to C$6.25 from C$5.20 at BMO Capital 01/08/21 CIBC Endeavour Silver price target raised to C$7.75 from C$7 at CIBC 01/08/21 Roth Capital Endeavour Silver price target raised to $6 from $5 at Roth Capital 01/08/21 H.C. Wainwright Endeavour Silver price target raised to $6.75 from $5.75 at H.C. Wainwright CPST Capstone Turbine $12.05 / +0.085 (+0.71%) 01/07/21 Craig-Hallum Capstone Turbine price target raised to $13 from $6 at Craig-Hallum 11/11/20 Lake Street Capstone Turbine price target raised to $7 from $5 at Lake Street 06/30/20 Maxim Capstone Turbine downgraded to Hold from Buy at Maxim INDO Indonesia Energy $6.18 / +0.38 (+6.55%) 04/27/20 Noble Capital Indonesia Energy initiated with an Outperform at Noble Capital 02/12/20 Fly Intel: Top five analyst initiations 02/12/20 Aegis Indonesia Energy initiated with a Buy at Aegis SMTS Sierra Metals $3.66 / +0.05 (+1.39%) 12/16/20 CIBC Sierra Metals price target raised to C$4.80 from C$3.50 at CIBC 11/10/20 CIBC Sierra Metals price target raised to C$3.50 from C$3.30 at CIBC 09/17/20 CIBC Sierra Metals price target raised to C$3.30 from C$2.60 at CIBC 09/11/20 CIBC CIBC starts Sierra Metals at Outperformer ahead of cash flow pickup CTXR Citius Pharmaceuticals $1.18 / +0.06 (+5.36%) JAGX Jaguar Health $3.26 / -0.01 (-0.31%) CURR CURE Pharmaceutical $0.00 / + (+0.00%) MIND MIND Technology $2.15 / -0.02 (-0.92%) 04/24/20 Kansas City Capital Mitcham Industries downgraded to Perform from Outperform at Kansas City Capital SSP E.W. Scripps $15.62 / +0.77 (+5.19%) 10/22/20 Fly Intel: Top five analyst initiations 10/22/20 Guggenheim E.W. Scripps resumed with a Buy at Guggenheim 07/07/20 Stitcher would help Sirius 'future-proof' business, says B. Riley FBR 06/25/20 Benchmark Benchmark sees material benefits if E.W. Scripps sells Stitcher LODE Comstock Mining $1.23 / -0.01 (-0.81%) 07/22/20 Noble Capital Comstock Mining initiated with an Outperform at Noble Capital VGZ Vista Gold $0.95 / -0.0432 (-4.35%) 11/09/20 Alliance Global Partners Vista Gold initiated with a Buy at Alliance Global Partners 10/26/20 Roth Capital Vista Gold coverage transferred with a Buy at Roth Capital 10/14/20 H.C. Wainwright Vista Gold price target raised to $3.25 from $2.50 at H.C. Wainwright AYLA Ayala Pharmaceuticals $14.65 / +1.85 (+14.45%) 12/07/20 Fly Intel: Top five analyst initiations 12/07/20 Roth Capital Ayala Pharmaceuticals initiated with a Buy at Roth Capital 12/02/20 Fly Intel: Top five analyst initiations 12/02/20 Noble Capital Ayala Pharmaceuticals initiated with an Outperform at Noble Capital STMH Stem Holdings $0.00 / + (+0.00%) EGLE Eagle Bulk Shipping $23.25 / +0.08 (+0.35%) 12/24/20 Noble Capital Eagle Bulk Shipping price target lowered to $30 from $32.50 at Noble Capital 07/29/20 DNB Markets Eagle Bulk Shipping upgraded to Buy from Hold at DNB Markets 03/09/20 DNB Markets Eagle Bulk Shipping downgraded to Hold from Buy at DNB Markets 01/27/20 Fearnley Eagle Bulk Shipping downgraded to Hold from Buy at Fearnley SALM Salem Media $1.61 / +0.04 (+2.55%) AEZS Aeterna Zentaris $0.69 / +0.0543 (+8.54%) GLDD Great Lakes Dredge $13.86 / -0.21 (-1.49%) INSW International Seaways $17.53 / -0.71 (-3.89%) 10/21/20 BTIG International Seaways downgraded to Neutral from Buy at BTIG 06/04/20 Pareto International Seaways downgraded to Hold from Buy at Pareto 06/02/20 Fearnley International Seaways downgraded to Sell from Buy at Fearnley 03/04/20 B. Riley FBR International Seaways upgraded to Buy from Neutral at B. Riley FBR CLBS EXK CPST MIND SSP AYLA EGLE AEZS GLDD INSW CLBS Caladrius $1.64 / +0.085 (+5.48%) 11/05/20 Caladrius reports Q3 EPS (29c), consensus (29c) 08/13/20 Caladrius reports Q2 EPS (50c), consensus (39c) EXK Endeavour Silver $4.28 / +0.065 (+1.54%) 11/05/20 Endeavour Silver reports Q3 EPS 0c, consensus 3c 11/05/20 Endeavour Silver reports Q3 EPS 0c, consensus 3c 11/05/20 Endeavour Silver reports Q3 EPS 0c, consensus 3c 08/04/20 Endeavour Silver reports Q2 EPS (2c), consensus 3c CPST Capstone Turbine $12.05 / +0.085 (+0.71%) 01/06/21 Capstone Turbine reports preliminary Q3 revenue $20.6M, consensus $16.42M 08/07/20 Capstone Turbine reports Q1 EPS (17c), consensus (21c) MIND MIND Technology $2.15 / -0.02 (-0.92%) 12/03/20 MIND Technology reports Q3 EPS (24c), one estimate (22c) SSP E.W. Scripps $15.62 / +0.77 (+5.19%) 11/06/20 E.W. Scripps reports Q3 EPS 76c, consensus 73c 08/07/20 E.W. Scripps reports Q2 cont ops EPS (22c), consensus (36c) AYLA Ayala Pharmaceuticals $14.65 / +1.85 (+14.45%) 11/17/20 Ayala Pharmaceuticals reports Q3 EPS (59c), consensus (54c) 08/13/20 Ayala Pharmaceuticals reports Q2 EPS (74c), consensus (53c) EGLE Eagle Bulk Shipping $23.25 / +0.08 (+0.35%) 11/05/20 Eagle Bulk Shipping reports Q3 EPS ($1.09), consensus (69c) AEZS Aeterna Zentaris $0.69 / +0.0543 (+8.54%) 11/06/20 Aeterna Zentaris reports Q3 EPS (2c) vs. (2c) last year GLDD Great Lakes Dredge $13.86 / -0.21 (-1.49%) 11/04/20 Great Lakes Dredge reports Q3 EPS 19c, two est. 16c 08/04/20 Great Lakes Dredge reports Q2 EPS from cont. ops. 14c, two est. 10c INSW International Seaways $17.53 / -0.71 (-3.89%) 11/06/20 International Seaways reports Q3 adjusted EPS 98c, consensus 70c 08/07/20 International Seaways reports Q2 EPS $2.39, consensus $2.43 18 Dec 08 May SSP SSP E.W. Scripps $15.62 / +0.77 (+5.19%) 10/02/20 Supreme Court to hear FCC push to ease media ownership rules, Reuters reports CPST CURR SSP STMH CPST Capstone Turbine $12.05 / +0.085 (+0.71%) 01/02/21 Week in review: How Trump's policies moved stocks CURR CURE Pharmaceutical $0.00 / + (+0.00%) 10/01/20 Rising High: An exclusive talk with drug delivery company CURE Pharmaceutical 07/30/20 Rising High: Cure to acquire Sera Labs as Biome Grow sells subsidiary SSP E.W. Scripps $15.62 / +0.77 (+5.19%) 09/24/20 Fly Intel: Wall Street's top stories for Thursday 09/24/20 Fly Intel: Wall Street's top stories at midday 09/24/20 Fly Intel: Pre-market Movers STMH Stem Holdings $0.00 / + (+0.00%) 12/31/20 Rising High: Canopy Rivers sells Canapar stake, Stem closes Driven deal 10/08/20 Rising High: Stem Holdings to acquire Driven Deliveries for C$41.3M 01/19/21 17th Annual Small & Microcap Virtual Investor Conference 03/15/21 33rd Annual Roth Virtual Conference 02/09/21 Capstone Turbine - CPST 03/01/21 Endeavour Silver - EXK UUUU EXK CPST LODE UUUU Energy Fuels $3.92 / -0.065 (-1.63%) 12/16/20 Largest borrow rate increases among liquid names 12/15/20 Largest borrow rate increases among liquid names 08/19/20 Largest borrow rate increases among liquid names 08/17/20 Largest borrow rate increases among liquid names EXK Endeavour Silver $4.28 / +0.065 (+1.54%) 08/17/20 Largest borrow rate increases among liquid names 07/30/20 Largest borrow rate increases among liquid names 07/21/20 Largest borrow rate increases among liquid names CPST Capstone Turbine $12.05 / +0.085 (+0.71%) 01/06/21 Fifteen new option listings on January 6th LODE Comstock Mining $1.23 / -0.01 (-0.81%) 09/03/20 Largest borrow rate increases among liquid names
General news	Week of 1/15 MBA Mortgage Applications to be released at 07:00 04:55 01/20/21 01/20 04:55 01/20/21 04:55

General news	Week of 1/16 Redbook to be released at 08:55 04:55 01/20/21 01/20 04:55 01/20/21 04:55
Conference/Events	Korn/Ferry management to meet virtually with Truist » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 KFY Korn/Ferry $46.89 / -0.25 (-0.53%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 7 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events KFY Korn/Ferry $46.89 / -0.25 (-0.53%) 11/24/20 Korn/Ferry says 'considerable uncertainty remains' around COVID impact 11/23/20 Korn/Ferry reports Q2 fee revenue $435.4M KFY Korn/Ferry $46.89 / -0.25 (-0.53%) 11/25/20 Baird Korn/Ferry upgraded to Outperform on improved margin profile at Baird 11/25/20 Baird Korn/Ferry upgraded to Outperform with $49 price target at Baird 11/25/20 Baird Korn/Ferry upgraded to Outperform from Neutral at Baird 11/24/20 Truist Korn/Ferry price target raised to $48 from $34 at Truist KFY Korn/Ferry $46.89 / -0.25 (-0.53%) 11/23/20 Korn/Ferry reports Q2 adj. EPS 54c, consensus 5c KFY Korn/Ferry $46.89 / -0.25 (-0.53%) 11/23/20 Fly Intel: Pre-market Movers 00:00 Today Korn/Ferry
Conference/Events	Calliditas Therapeutics to host virtual research and development day » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 CALT Calliditas Therapeutics $31.90 / +1.35 (+4.42%) Research and Development… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events CALT Calliditas Therapeutics $31.90 / +1.35 (+4.42%) 01/18/21 Calliditas says Phase 1 setanaxib trial shows favorable pharmacokinetic profile 11/09/20 Calliditas Therapeutics says Part A of NefIgArd trial met its primary objective CALT Calliditas Therapeutics $31.90 / +1.35 (+4.42%) 07/01/20 Citi Calliditas Therapeutics initiated with a Buy at Citi 06/30/20 Jefferies Calliditas Therapeutics initiated with a Buy at Jefferies 06/30/20 Stifel Calliditas Therapeutics initiated with a Buy at Stifel 05 Jun 07:00 Today Calliditas Therapeutics
General news	Housing Market Index to be reported at 10:00 » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 January Housing Market… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	ASML management to meet virtually with Evercore ISI » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 ASML ASML $549.18 / +21.25 (+4.03%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 6 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Periodicals Events ASML ASML $549.18 / +21.25 (+4.03%) 01/19/21 Barclays ASML price target raised to EUR 525 from EUR 475 at Barclays 01/15/21 JPMorgan ASML price target raised to EUR 437 from EUR 408 at JPMorgan 01/14/21 Barclays ASML price target raised to EUR 475 from EUR 425 at Barclays 01/13/21 UBS ASML price target raised to EUR 430 from EUR 395 at UBS ASML ASML $549.18 / +21.25 (+4.03%) 10/14/20 ASML sees Q4 revenue EUR3.6B-EUR3.8B 10/14/20 ASML reports Q3 EPS EUR2.54 vs. EUR1.79 last quarter ASML ASML $549.18 / +21.25 (+4.03%) 11/13/20 TSMC places EUV equipment orders with ASML for 2021, DigiTimes reports 02/11/21 Technology & Internet Virtual Conference 01/26/21 ASML 01/27/21 ASML

Conference/Events	FDA PDUFA Date for Merck & Bayer Vericiguat is January 20, 2021 04:55 01/20/21 01/20 04:55 01/20/21 04:55 MRK Merck $83.18 / -0.215 (-0.26%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MRK Merck $83.18 / -0.215 (-0.26%) 01/19/21 Cocrystal Pharma completes research obligations under Merck agreement 01/19/21 Atea Pharmaceuticals appoints Jayanthi Wolf as SVP, regulatory affairs 01/14/21 Philips. Merck partner on personalized fertility treatment solutions 01/13/21 Ligand will get $1.5M milestone payment from Merck MRK Merck $83.18 / -0.215 (-0.26%) 01/06/21 Citi Citi opens 'positive catalyst watch' on Merck 01/05/21 Citi Citi boosts Merck target to $105, says may be most undervalued in pharma 12/22/20 Mizuho Autolus, Arcus among top 2021 oncology picks at Mizuho 12/21/20 Alliance Global Partners Alliance Global Partners keeps Buy on Sellas following data from trials MRK Merck $83.18 / -0.215 (-0.26%) 10/27/20 Merck raises FY20 adjusted EPS view to $5.91-$6.01 from $5.63-$5.78 10/27/20 Merck reports Q3 adjusted EPS $1.74, consensus $1.43 10/26/20 Notable companies reporting before tomorrow's open 10/26/20 Notable companies reporting before tomorrow's open MRK Merck $83.18 / -0.215 (-0.26%) 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports MRK Merck $83.18 / -0.215 (-0.26%) 12/26/20 Week in review: How Trump's policies moved stocks 12/02/20 Fly Intel: Wall Street's top stories at midday 12/02/20 Fly Intel: Pre-market Movers 11/23/20 Fly Intel: Wall Street's top stories for Monday 02/04/21 Merck - MRK 00:00 Today PDUFA Date for Vericiguat 02/09/21 Oncologic Drugs Advisory Committee Virtual Meeting 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 MRK Merck $83.18 / -0.215 (-0.26%) 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish 08/06/20 Unusually active option classes on open August 6th 08/05/20 Merck call volume above normal and directionally bullish
General news	Week of 1/16 Redbook to be released at 08:55 04:55 01/20/21 01/20 04:55 01/20/21 04:55
Conference/Events	Stephens food/agribusiness analyst holds an analyst/industry conference call » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 Food/Agribusiness Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 7 minutes Get Free Trial
Conference/Events	Aqua Metals management to meet virtually with Oppenheimer » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 AQMS Aqua Metals $4.84 / +1.1 (+29.41%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events AQMS Aqua Metals $4.84 / +1.1 (+29.41%) 12/28/20 Aqua Metals completes V1.25L electrolyzer program on time, under budget 09/29/20 Aqua Metals receives additional $1.5M insurance payment 09/22/20 Aqua Metals announces intention to sell McCarran, Nevada plant 08/26/20 Aqua Metals receives additional $5.279M Layer 3 insurance payment AQMS Aqua Metals $4.84 / +1.1 (+29.41%) 03/12/20 Oppenheimer Aqua Metals price target lowered to $2 from $9 at Oppenheimer 01/27/21 Aqua Metals - AQMS 00:00 Today Aqua Metals
Conference/Events	G1 Therapeutics management to meet virtually with Roth Capital » 04:55 01/20/21 01/20 04:55 01/20/21 04:55 GTHX G1 Therapeutics $21.67 / +0.85 (+4.08%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GTHX G1 Therapeutics $21.67 / +0.85 (+4.08%) 12/09/20 G1 Therapeutics says trilaciclib showed improved OS in Phase 2 trial 11/18/20 G1 Therapeutics to present clinical data on trilaciclib, rintodestrant 09/30/20 G1 Therapeutics CEO Mark Velleca to move to new role, John Bailey to succeed 08/17/20 G1 Therapeutics announces FDA acceptance of trilaciclib NDA GTHX G1 Therapeutics $21.67 / +0.85 (+4.08%) 11/17/20 Raymond James Raymond James downgrades G1 Therapeutics after removing rintodestrant from model 11/17/20 Raymond James G1 Therapeutics downgraded to Outperform from Strong Buy at Raymond James 07/01/20 Wedbush G1 Therapeutics price target lowered to $50 from $55 at Wedbush 06/26/20 Roth Capital G1 Therapeutics initiated with a Buy at Roth Capital GTHX G1 Therapeutics $21.67 / +0.85 (+4.08%) 11/04/20 G1 Therapeutics sees ending year with cash, cash equivalents of $200M-$205M 11/04/20 G1 Therapeutics reports Q3 EPS (31c), consensus (30c) 08/05/20 G1 Therapeutics reports Q2 EPS (83c), consensus (83c) 02/15/21 PDUFA Date for Trilaciclib 00:00 Today G1 Therapeutics

Events

Earnings calls, analyst events, roadshows and more

Today at 07:00

MBA Mortgage Applications: Refinance Index W/W: 1/15/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Composite Index W/W: 1/15/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Purchase Index W/W: 1/15/2021 Government Event
CALT
Today at 07:00

Calliditas Therapeutics Firm Sponsored Meetings

Virtual Meeting
CFG
Today at 08:00

Citizens Financial - CFG Conference Calls
BK
Today at 08:00

BNY Mellon - BK Conference Calls
MESO
Today at 08:00

Mesoblast - MESO Conference Calls
Today at 08:00

Homebuilders Industry Meetings

Virtual Meeting
FNB
Today at 08:15

F.N.B. - FNB Conference Calls
PG
Today at 08:30

Procter & Gamble - PG Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital $32.80 Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright $17.00-18.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald $1.90-2.00 BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright $3.17 4.167M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim $9.14 CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $64.18 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse $11.73 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel $22.00-23.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE $13.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler $14.95 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares
Fri	No deals

View All Syndicate Announcements »

Preliminary option volume of 32.5M today

TODAY'S FREE FLY STORIES

Get Full Fly Access